NCT05497518 The KidneyCARE (Community Access to Research Equity) Study
| NCT ID | NCT05497518 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Tufts Medical Center |
| Condition | Chronic Kidney Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 50,000 participants |
| Start Date | 2021-02-25 |
| Primary Completion | 2070-02-24 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 50,000 participants in total. It began in 2021-02-25 with a primary completion date of 2070-02-24.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
For chronic kidney disease (CKD), there is a lack of unique and powerful platform for patient engagement, research studies and public health advocacy work. The National kidney Foundation (NKF) launched the first nationwide registry for people at all stages and types of CKD, including people on dialysis and kidney transplant recipients, called the KidneyCARE Study (kidneycarestudy.org). The KidneyCARE Study is a non-interventional research study which means participants will not have to take medications or do any additional tests to participate. They are simply asked to share some personal and health information, and their experiences with their disease through a secure portal. The Study also collaborates with health systems to obtain additional electronic health records (EHR) data. This unique combination of data collected will address the gap of individualized educational resources and will enhance clinical research, clinical care, and health policy decisions to be centered on the patient. The Study is all online and can be accessed any time of day at kidneycarestudy.org. Participation is voluntary and free.
Eligibility Criteria
Inclusion Criteria: * Patients with any stage of CKD, including kidney transplant recipients and patients on dialysis. * Age 18 years and above. * Willing to participate in the Study and complete the informed consent form and assent form (where applicable). * Able to participate in this Study, which initially will be in English and then eventually expand to other languages. * Patients affiliated with Geisinger Health System must have given their consent to Geisinger Health System IRB to be contacted for research projects. Exclusion Criteria: * Patient not diagnosed with CKD * Age below 18 years * Not willing to participate in the Study as well as unwilling to complete the informed consent form
Contact & Investigator
Kerry Willis, PhD
STUDY DIRECTOR
National Kidney Foudnation
Frequently Asked Questions
Who can join the NCT05497518 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 120 Years, studying Chronic Kidney Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05497518 currently recruiting?
Yes, NCT05497518 is actively recruiting participants. Contact the research team at LInker@Tuftsmedicalcenter.org for enrollment information.
Where is the NCT05497518 trial being conducted?
This trial is being conducted at Danville, United States.
Who is sponsoring the NCT05497518 clinical trial?
NCT05497518 is sponsored by Tufts Medical Center. The principal investigator is Kerry Willis, PhD at National Kidney Foudnation. The trial plans to enroll 50,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.